Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

paclitaxel albumin-stabilized nanoparticle formulation

(PA-klih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kul for-myoo-LAY-shun)
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Paclitaxel albumin-stabilized nanoparticle formulation may have fewer side effects and work better than other forms of paclitaxel. It is also being studied in the treatment of other types of cancer. Paclitaxel albumin-stabilized nanoparticle formulation stops cancer cells from growing and dividing and may kill them. It is a type of taxane. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and protein-bound paclitaxel.
More Information
Search NCI's Dictionary of Cancer Terms